ARTICLE | Clinical News
Avid Therapeutics regulatory update
October 10, 1994 7:00 AM UTC
The Philadelphia company received two U.S. Patents covering its technologies for discovering drugs targeted at hepatitis B and herpes. Patent No. 5,334,524, licensed by Avid from the Fox Chase Cancer ...